Federal Register / Vol. 75, No. 65 / Tuesday, April 6, 2010 / Notices 17393 

questionnaires, interviewer guidelines, 

and other instruments and instructions 

used to collect the information, conduct 

face-to-face and telephone interviews; 

and evaluate responses obtained from 

interviews and completed forms. Each 

staff month is estimated to cost the 

Commission approximately $13,859. 

This is based on an average wage rate of 

$55.97 (the equivalent of a GS–14 Step 

5 employee) with an addition 30 percent 

added for benefits (Bureau of Labor 

Statistics, June 2009, percentage total 

benefits for all civilian management, 

professional, and related employees). 

Dated: March 31, 2010. 

Todd A. Stevenson, 

Secretary, Consumer Product Safety 

Commission. 

[FR Doc. 2010–7670 Filed 4–5–10; 8:45 am] 

BILLING CODE 6355–01–P 

DEPARTMENT OF DEFENSE 

Department of the Army; Corps of 

Engineers 

Intent To Prepare a Draft 

Environmental Impact Statement for 

the ‘‘Flood Control, Mississippi River & 

Tributaries, St. Johns Bayou and New 

Madrid Floodway, Missouri, First 

Phase’’ (SJNM) Project 

AGENCY: Department of the Army, U.S. 

Army Corps of Engineers, DoD. 

ACTION: Notice of intent to prepare a 

DEIS. 

SUMMARY: The U.S. Army Corps of 

Engineers is announcing its intent to 

prepare a Draft Environmental Impact 

Statement (DEIS) for the Mississippi 

River and Tributaries, St. Johns Bayou 

and New Madrid Floodway, MO Project. 

The DEIS is being prepared to address 

and evaluate the environmental, 

economic and social impacts of 

alternative plans to provide flood 

control and develop and discuss 

locations and methodologies of 

potential compensatory mitigation. This 

DEIS will address previous project 

history, independent external peer 

reviews, State/Federal agency concerns 

and will formulate alternatives that 

manage flood risks in the project area. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Gregg Williams, telephone (901) 544– 

3852, CEMVM–PB–E, 167 North Main 

Street B–202, Memphis, TN 38103– 

1894, e-mail— 

Gregg.W.Williams@usace.army.mil. 

SUPPLEMENTARY INFORMATION: The St. 

Johns Bayou Basin and New Madrid 

Floodway are located in the Bootheel 

region of southeast Missouri and 

include all or portions of the New 

Madrid, Scott and Mississippi Counties. 

The basin and floodway are adjacent to 

the Mississippi River, extending from 

the vicinity of Commerce, Missouri to 

New Madrid, Missouri. The basin and 

floodway are subject to both backwater 

and interior headwater flooding. 

Congress authorized the Mississippi 

River and Tributaries (MR&T) Project to 

construct the mainline Mississippi River 

levees. The Birds Point-New Madrid 

Floodway was part of the 1928 Flood 

Control Act. A levee closure and outlet 

structure at New Madrid, Missouri were 

authorized in the Flood Control Act of 

1954 (Pub. L. 780–83) but not 

constructed. The St. Johns Bayou Basin 

levee closure, with drainage structure, 

was authorized in the Flood Control Act 

of 1946, and subsequently constructed. 

An EIS for the MR&T and Channel 

Improvement was filed with the Council 

on Environmental Quality in July 1976, 

which addressed the New Madrid 

Floodway levee closure. The St. Johns 

Bayou/New Madrid Floodway Project 

Final Supplemental Environmental 

Impact Statement (SEIS) was filed with 

the EPA in July 1982. The current 

project was authorized for construction 

by the Water Resources Development 

Act of 1986 (Pub. L. 99–662), section 

401(a). The authorized project is based 

on the Report of the Chief of Engineers, 

dated January 4, 1983, which is part of 

the Phase I General Design 

Memorandum (GDM) documents 

prepared in response to section 101(a) of 

the Water Resources Development Act 

of 1976 (Pub. L. 94–587). A Revised 

Supplemental Environmental Impact 

Statement (RSEIS) was filed in June 

2002. The Revised Supplemental 

Environmental Impact Statement 2 

(RSEIS2) was prepared to clarify the 

record and address concerns related to 

the calculation of compensatory 

mitigation for mid-season fishery 

impacts, hypoxia, cost-benefit analysis, 

Swampbuster and the applicable 

discount rate in the economics analysis. 

The RSEIS2 was filed in March 2006. 

The Corps has determined that a new 

EIS is required to incorporate additional 

scientific and engineering data; include 

the results of intensive independent 

external peer review of the previous 

project document, plans and studies; 

clarify project objectives and plans; and 

address points raised in the course of 

legal action. 

1. Proposed Action: The authorized 

project for the St. Johns Bayou and New 

Madrid Floodway Project consists of 

channel enlargement and improvement 

in the St. Johns Bayou Basin along the 

lower 4.5 miles of the St. Johns Bayou, 

beginning at New Madrid, Missouri, 

then continuing 8.1 miles along the 

Birds Point-New Madrid Setback Levee 

Ditch and ending with 10.8 miles along 

the St. James Ditch. The first item of 

work, consisting of selective clearing 

and snagging, has already been 

completed along a 4.3-mile reach of the 

Setback Levee Ditch beginning at the 

confluence with the St. James Ditch. 

The authorized project also includes a 

1,000-cubic-foot-per-second (CFS) 

pumping station for the St. Johns Bayou 

Basin area, a 1,500-CFS pumping station 

for the New Madrid Floodway area and 

a 1,500-foot-closure levee at the 

southern end of the New Madrid 

Floodway. The channel enlargement 

work and both pumping stations are 

features of the St. Johns Bayou and New 

Madrid Floodway Project and the levee 

closure is a feature of the Mississippi 

River Levee Project. 

2. Alternatives: Alternatives to 

manage flood risks in the project area 

will be considered. Comparisons will be 

made among the alternative plans, 

including the ‘‘no action’’ alternative. 

3. Scoping Process: An intensive 

public involvement program has been 

set up to (1) solicit input from 

individuals and interested parties so 

that problems, needs and opportunities 

within the project area can be properly 

identified and addressed and (2) 

provide status updates to concerned 

organizations and the public. Significant 

issues being analyzed include potential 

project impacts (negative and positive) 

to fisheries, water quality, wetlands, 

waterfowl, shorebirds, endangered 

species and cultural resources. 

Meetings with the local sponsor, 

public coordination meetings, 

interagency environmental meetings 

and public project briefings/ 

presentations will be conducted 

throughout this process. This notice is 

being circulated to Federal, State and 

local environmental resource and 

regulatory agencies; Indian Tribes; nongovernmental organizations; and the 

general public. This notice of intent 

(NOI) will serve as a request for scoping 

input. All interested parties are 

encouraged to participate in the scoping 

process. A public scoping meeting will 

be held on May 11, 2010, at 7 p.m. in 

the East Prairie Church of God, 322 N. 

Washington St., East Prairie, MO 63845. 

It is anticipated that the DEIS will be 

available for public review during 

spring 2012. A public meeting will be 

held during the review period to receive 


sroberts on DSKD5P82C1PROD with NOTICES
17394 Federal Register / Vol. 75, No. 65 / Tuesday, April 6, 2010 / Notices 

comments and address questions 

concerning the draft report. 

Thomas P. Smith, 

Colonel, Corps of Engineers, District 

Commander. 

[FR Doc. 2010–7720 Filed 4–5–10; 8:45 am] 

BILLING CODE 3720–58–P 

DEPARTMENT OF DEFENSE 

Department of the Navy 

Notice of Availability of GovernmentOwned Inventions; Available for 

Licensing 

AGENCY: Department of the Navy, DoD. 

ACTION: Notice. 

SUMMARY: The Department of the Navy 

hereby gives notice of the availability of 

exclusive or partially exclusive licenses 

to practice worldwide under the 

following pending patents. Any license 

granted shall comply with 35 U.S.C. 209 

and 37 CFR part 404. Applications will 

be evaluated utilizing the following 

criteria: (1) Ability to manufacture and 

market the technology; (2) 

manufacturing and marketing ability; (3) 

time required to bring technology to 

market and production rate; (4) 

royalties; (5) technical capabilities; and 

(6) small business status. 

11/700,970, ‘‘Interim dental dressing 

and restorative material’’, filed on 

January 24, 2007, Inventors: Amer Tiba, 

David Charlton, and James Ragain; 

11/726,203, ‘‘Method for the detection of 

target molecules by fluorescence 

polarization using peptide mimics’’, 

filed on March 13, 2007, Inventors: 

Malford Cullum, Karen O’Connor; 

11/789,122, ‘‘Recombinant antigens for 

diagnosis and prevention of murine 

typhus’’, filed on April 19, 2007, 

Inventor: Wei Mei Ching; 11/800,955, 

‘‘Secreted campylobacter flagella 

coregulated proteins as immunogens’’, 

filed on May 8, 2007, Inventor: Pat 

Guerry; 11/800,948, ‘‘Multifunctional 

blood substitute (MBS)’’, filed on May 8, 

2007, Inventor: Daniel Freilich; 

11/881,498, ‘‘Recombinant antigens for 

diagnosis and prevention of murine 

typhus (Murine typhus Ompb derived A 

and K fragments (similar to r56))’’, filed 

on July 27, 2007, Inventor: Wei Mei 

Ching; 11/839,922, ‘‘Vascular shunt 

created from ptfe 

(polytetrafluoroethylene) or other novel 

non-coagulative materials’’, filed on 

August 16, 2007, Inventor: H.D. Elshire; 

11/842,438, ‘‘Methods for protecting 

against lethal infection with bacillus 

anthracis’’, filed on August 21, 2007, 

Inventors: Darrell Galloway and Alfred 

Mateczun; 11/876,997, ‘‘Orientia 

tsutsugamushi truncated recombinant 

outer membrane protein (r47 and r57) 

vaccines diagnostics and therapeutics 

for scrub typhus and HIV infections’’, 

filed on October 23, 2007, Inventors: 

Wei Mei Ching, Chien Chung Chao, and 

Hong Ge; 11/982,488, ‘‘Induction of an 

immune response against dengue virus 

using the prime-boost approach’’, filed 

on November 2, 2007, Inventors: 

Monika Simmons, and Kevin Porter; 11/ 

942,402, ‘‘Methods for protection against 

lethal infection with bacillus anthracis’’, 

filed on November 19, 2007, Inventors: 

Darrell Galloway and Alfred Mateczun; 

11/942,343, ‘‘Methods for protection 

against lethal infection with bacillus 

anthracis’’, filed on November 19, 2007, 

Inventors: Darrell Galloway And Alfred 

Mateczun; 12/001,599, ‘‘Identification of 

antigens for diagnosis and prevention of 

Q fever (recombinant antigens for the 

detection of coxiella burnetii)’’, filed on 

December 11, 2007, Inventors: Wei Mei 

Ching and Chien Chung Chao; 

12/001,598, ‘‘Identification of antigens 

for diagnosis and prevention of Q fever 

(recombinant antigens for the detection 

of coxiella burnetii),’’ filed on December 

11, 2007, Inventors: Wei Mei Ching and 

Chien Chung Chao; 11/964,982, 

‘‘Expression and refolding of truncated 

recombinant major outer membrane 

protein antigen (R56) of orientia 

tsutsugamushi and its use in antibody 

based detection assays and vaccines’’, 

filed on December 27, 2007, Inventors: 

Wei Mei Ching, Gregory Dasch and 

Daryl Kelly; 11/965,004, ‘‘Expression 

and refolding of truncated recombinant 

major outer membrane protein antigen 

(R56) of orientia tsutsugamushi and its 

use in antibody based detection assays 

and vaccines,’’ filed on December 28, 

2007, Inventors: Wei Mei Ching, 

Gregory Dasch, and Daryl Kelly; 11/ 

971,433, ‘‘Adenoviral vector-based 

malaria vaccine’’, filed on January 9, 

2008, Inventors: Joseph Bruder, Richter 

King, Keith Limbach, Denise Doolan, 

and Tom Richie; 11/988,598, ‘‘Adhesinenterotoxoid chimera vaccine for 

enterotoxigenic escherichia coli’’, filed 

on January 10, 2008, Inventor: Stephen 

Savarino; 12/028,241, ‘‘RF diathermy 

and faradic muscle stimulation 

treatment,’’ filed on February 8, 2008, 

Inventors: James Bingham and Richard 

Olsen; 12/103,112, ‘‘Recycling container 

(to minimize release of HG vapor) for 

the collection and temporary storage of 

mercury contaminated wastes in the 

dental operatory,’’ filed on April 15, 

2008, Inventors: Mark Stone, Ronald 

Karaway, and Denise Berry; 12/163,412, 

‘‘Fluorescence polarization instruments 

and methods for detection of exposure 

to biological materials by fluorescence 

polarization immunoassay of saliva or 

oral fluid’’, filed on June 27, 2008, 

Inventors: Malford Cullum, Linda 

Lininger, Ernest Pederson, Sylvia 

Schade, and Lloyd Simonson; 12/ 

221,150, ‘‘Capsule composition for use 

as immunogen against campylobacter 

jejuni’’, filed on July 25, 2008, Inventors: 

Pat Guerry and Mario Monteiro; 12/ 

255,861, ‘‘Methods for treating HIV 

infected subjects’’, filed on October 22, 

2008, Inventors: Carl June, Craig 

Thompson, Gary Nabel, Gary Gray, and 

Paul Rennert; 12/064,554, ‘‘Adenoviral 

vector-based malaria vaccines’’, filed on 

October 27, 2008, Inventors: Joseph 

Bruder, Imre Kovesdi, Richter King, 

Duncan Mcvey, Damodar Ettyreddy, 

Denise Doolan, Daniel Carucci, and 

Keith Limbach; 12/362,622, 

‘‘Multifunctional acrylates used as crosslinkers in dental and biomedical selfetch bonding adhesives’’, filed on 

January 30, 2009, Inventors: James 

Ragain, Amer Tiba, and David Charlton; 

12/454,038, ‘‘Recombinant antigens for 

diagnosis and prevention of murine 

typhus’’, filed on April 27, 2009, 

Inventor: Wei Mei Ching; 12/454,496, 

‘‘Dengue virus detection measured by 

immunocytometry in a dendritic cell 

surrogate’’, filed on April 27, 2009, 

Inventors: Timothy Burgess, Jeffrey 

Tjaden, Kevin Porter, and Mary 

Marovich; 12/467,533, ‘‘Recombinant 

chimeric antigens for diagnosis and 

prevention of scrub typhus’’, filed on 

May 18, 2009, Inventors: Wei Mei 

Ching, and Chien Chung Chao; 12/ 

480,290, ‘‘Recombinant antigens for 

diagnosis and prevention of spotted 

fever rickettsiae’’, filed on June 8, 2009, 

Inventors: Wei Mei Ching and Hua-Wei 

Chin; 12/522,335, ‘‘Adenoviral vectorbased malaria vaccines’’, filed on July 7, 

2009, Inventor: Joseph Bruder; 12/ 

501,021, ‘‘Composition and method for 

the induction of immunity against 

bacillus cereus group bacteria’’, filed on 

July 10, 2009, Inventors: Sanghamitra 

Mukhopadhyay and Timothy Read; 12/ 

569,821, ‘‘Functional role of 

adrenomedullin (AM) and the gene 

related product (PAMP) in human 

pathology and physiology’’, filed on 

September 29, 2009, Inventors: Frank 

Cuttitta, Alfredo Martinez, Mac Jean 

Miller, Edward Unsworth, William 

Hook, Thomas Walsh, Karen Gray, and 

Charles Macri; 12/634,119, ‘‘CCD 

contrast enhancement for in vivo 

oxygenation measurements’’, filed on 

December 9, 2009, Inventors: Nicole 

Crane, Eric Elster, Doug Tadaki, Scott 

Huffman, and Ira Levin; 12/672,361, 

‘‘Photoacoustic laser joulemeter utilizing 

beam deflection technique’’, filed on 

February 5, 2010, Inventors: Sahir 


sroberts on DSKD5P82C1PROD with NOTICES